Evidence map›Paper›PMID 41449452›Full record

ReviewJournal of nanobiotechnology2025

Ultrasound-responsive micro/nanobubbles based intelligent theranostic systems for precision tumor therapy.

Deng Liu, Yi Ling, Wanqian Liu, Jun Deng, Yanli Guo

Abstract readReview
In one paragraph

Review in Journal of nanobiotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Emerging Nanoplatforms are Effective Against Tumor Hypoxia.International journal of nanomedicine · 2026
    Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Deng LiuKey Laboratory of Biorheological Science and Technology, Ministry of Education& 111 Project Laboratory of Biomechanics and Tissue Repair, Bioengineering College, Chongqing University, Chongqing, 400044, China.
Yi LingDepartment of Ultrasound, The First Affiliated Hospital (Southwest Hospital) of Army Medical University, Chongqing, 400038, China.
Wanqian LiuKey Laboratory of Biorheological Science and Technology, Ministry of Education& 111 Project Laboratory of Biomechanics and Tissue Repair, Bioengineering College, Chongqing University, Chongqing, 400044, China. wqliu@cqu.edu.cn.
Jun DengInstitute of Burns, State Key Lab of Trauma and Chemical Poisoning, The First Affiliated Hospital (Southwest Hospital) of Army Medical University, Chongqing, 400038, China. djun.123@163.com.
Yanli GuoDepartment of Ultrasound, The First Affiliated Hospital (Southwest Hospital) of Army Medical University, Chongqing, 400038, China. guoyanli@tmmu.edu.cn.

Funding

Chongqing Special Key Project of Technology Innovation and Application Development, China CSTB2022TIAD-KPX0153National Natural Science Foundation of China 12172072National Natural Science Foundation of China 82171956Talent Plan of Chongqing 425Z2K1
6 · The paper itself

Abstract

Ultrasound-targeted micro/nanobubble cavitation (UTMC/UTNC) has emerged as a highly promising ultrasound-based strategy for precision tumor therapy. This technique harnesses microbubbles and nanobubbles as cavitation nuclei that respond to ultrasound, inducing cavitation effects, generating mechanical forces that transiently permeabilize biological barriers, enhance vascular and cellular permeability, and induce localized tumor cell disruption. These cavitation-mediated effects enable spatiotemporally controlled drug release, markedly improving intratumoral drug accumulation and maximizing therapeutic efficacy while reducing systemic toxicity. This review provides a comprehensive overview of the mechanistic foundations and therapeutic applications of UTMC/UTNC. The physical mechanisms by which bubbles act as cavitation nuclei, undergoing oscillation, expansion, collapse, or rupture under ultrasound stimulation, and their resulting biological effects are discussed in detail. Furthermore, emphasizing the roles of UTMC/UTNC in enhancing chemotherapy, sonodynamic therapy, immunotherapy, gene delivery, radiotherapy, and ferroptosis is reviewed. These therapeutic enhancements are primarily attributed to improved drug delivery and cavitation-induced tumor cell disruption. Finally, key challenges and limitations associated with UTMC/UTNC-mediated tumor therapy are discussed, along with prospects for clinical translation.

Indexed as

MicrobubblesNanoparticlesNeoplasmsPrecision MedicineTheranostic NanomedicineUltrasonic TherapyAnimalsAntineoplastic AgentsDrug Delivery SystemsHumansAntineoplastic AgentsCavitation effectDrug deliveryMicro/nanobubblesTumor diagnosis and therapyUltrasound-targeted micro/Nanobubble cavitation (UTMC/UTNC)

Identifiers

PMID41449452
PMCPMC12849389

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.